Clinical trials for children with cancer in Europe -Still a long way from harmonisation : A report from SIOP EuropePRITCHARD-JONES, K.European journal of cancer (1990). 2008, Vol 44, Num 15, pp 2106-2111, issn 0959-8049, 6 p.Article

Controversies and advances in the management of Wilms' tumourPRITCHARD-JONES, K.Archives of disease in childhood. 2002, Vol 87, Num 3, pp 241-244, issn 0003-9888, 4 p.Article

Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours : implications for tumour histogenesisPRITCHARD-JONES, K; FLEMING, S.Oncogene (Basingstoke). 1991, Vol 6, Num 12, pp 2211-2220, issn 0950-9232Article

The Wilms tumour gene, WT1, in normal and abnormal nephrogenesisPRITCHARD-JONES, K.Pediatric nephrology (Berlin, West). 1999, Vol 13, Num 7, pp 620-625, issn 0931-041XConference Paper

Principles of Wilms' tumor biologyCOPPES, M. J; PRITCHARD-JONES, K.Urologic clinics of North America. 2000, Vol 27, Num 3, issn 0094-0143, viii,423-433 [12 p.]Article

Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistanceKING-UNDERWOOD, L; PRITCHARD-JONES, K.Blood. 1998, Vol 91, Num 8, pp 2961-2968, issn 0006-4971Article

Genetics of childhood cancerPRITCHARD-JONES, K.British medical bulletin. 1996, Vol 52, Num 4, pp 704-723, issn 0007-1420Article

Mutations in the Wilms' tumor gene WT1 in leukemiasKING-UNDERWOOD, L; RANSHAW, J; PRITCHARD-JONES, K et al.Blood. 1996, Vol 87, Num 6, pp 2171-2179, issn 0006-4971Article

What can we learn from geographical comparisons of childhood cancer survival?PRITCHARD-JONES, K; STILLER, C.British journal of cancer. 2007, Vol 96, Num 10, pp 1493-1497, issn 0007-0920, 5 p.Article

The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patientPRITCHARD-JONES, K; RENSHAW, J; KING-UNDERWOOD, L et al.Human molecular genetics (Print). 1994, Vol 3, Num 9, pp 1633-1637, issn 0964-6906Article

PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cellsTIFFIN, N; WILLIAMS, R. D; SHIPLEY, J et al.British journal of cancer. 2003, Vol 89, Num 2, pp 327-332, issn 0007-0920, 6 p.Article

EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin): chemotherapy selected for multidrug resistance modulationDAVIDSON, A; DICK, Gina; PRITCHARD-JONES, K et al.European journal of cancer (1990). 2002, Vol 38, Num 18, pp 2422-2427, issn 0959-8049, 6 p.Article

Population survival from childhood cancer in Britain during 1978―2005 by eras of entry to clinical trialsSTILLER, C. A; KNOLL, M. E; PRITCHARD-JONES, K et al.Annals of oncology. 2012, Vol 23, Num 9, pp 2464-2469, issn 0923-7534, 6 p.Article

The significance of an M2 bone marrow at cessation of chemotherapy in childhood acute lymphoblastic leukemiaPRITCHARD-JONES, K; TOOGOOD, I. R. G; RICE, M. S et al.The American journal of pediatric hematology/oncology. 1988, Vol 10, Num 4, pp 292-295, issn 0192-8562Article

T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55ULLENHAG, G. J; SPENDLOVE, I; WATSON, N. F. S et al.Clinical immunology (Orlando, Fla. Print). 2008, Vol 128, Num 2, pp 148-154, issn 1521-6616, 7 p.Article

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumourNATRAJAN, R; LITTLE, S. E; PRITCHARD-JONES, K et al.Journal of pathology. 2007, Vol 211, Num 1, pp 52-59, issn 0022-3417, 8 p.Article

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcomaPRITCHARD-JONES, K; SPENDLOVE, I; ALVAREZ, P et al.British journal of cancer. 2005, Vol 92, Num 8, pp 1358-1365, issn 0007-0920, 8 p.Article

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21RAHMAN, N; ARBOUR, L; TONIN, P et al.Nature genetics. 1996, Vol 13, Num 4, pp 461-463, issn 1061-4036Article

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryoARMSTRONG, J. F; PRITCHARD-JONES, K; BICKMORE, W. A et al.Mechanisms of development. 1993, Vol 40, Num 1-2, pp 85-97, issn 0925-4773Article

Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: A Study by the United Kingdom Children's Cancer Study group, wilm's tumor working GroupPRITCHARD-JONES, K; KELSEY, A; VUJANIC, G et al.Journal of clinical oncology. 2003, Vol 21, Num 17, pp 3269-3275, issn 0732-183X, 7 p.Article

High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistanceCOCKER, H. A; HOBBS, S. M; TIFFIN, N et al.British journal of cancer. 2001, Vol 85, Num 11, pp 1746-1752, issn 0007-0920Article

Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantationATRA, A; MILLAR, B; SHEPHERD, V et al.British journal of haematology. 1997, Vol 97, Num 1, pp 165-168, issn 0007-1048Article

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcomaZIBAT, A; MISSIAGLIA, E; ROSENBERGER, A et al.Oncogene (Basingstoke). 2010, Vol 29, Num 48, pp 6323-6330, issn 0950-9232, 8 p.Article

Loci other than 21q22.12 (RUNX1) and 16q21-23.2 cause familial AMLSELLICK, G. S; PRITCHARD-JONES, K; SHEPHERD, V et al.Leukemia. 2005, Vol 19, Num 3, pp 465-466, issn 0887-6924, 2 p.Article

Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell linesCOWIE, F. J; PRITCHARD-JONES, K; RENSHAW, J et al.International journal of oncology. 1998, Vol 12, Num 5, pp 1143-1149, issn 1019-6439Article